Sharpen DTX Secures SCRA Grant to Accelerate Go-to-Market Strategy

We're thrilled to announce that Sharpen DTX has been awarded a grant from the South Carolina Research Authority (SCRA) to develop and validate our go-to-market strategy with healthcare payors and providers.

The grant enables us to partner with Ainsley Advisory Group, bringing deep expertise from Dr. MacLean and her team in healthcare reimbursement and payor landscapes directly into our strategic planning. With Ainsley's guidance, we'll pressure test our business model, refine our pricing strategy, and build concrete pathways to sustainable revenue growth—all crucial de-risking activities as we prepare for our Series Seed round in 2026.

Building a Comprehensive Market Playbook

Through this collaboration, we're developing a strategic playbook that addresses the unique needs of both providers and payors. This project runs in parallel with our participation in Creative Destruction Lab, creating powerful synergies between technical refinement and business model validation. Together, these programs are accelerating our path to market and strengthening our foundation for growth.

Gratitude and Looking Ahead

This grant validates the work we've already accomplished with early partners at Prisma Health and Stanford Medicine and provides the resources and expertise to transform that early traction into a repeatable, scalable business model.

Thank you to SCRA for believing in our mission to make evidence-based behavioral health interventions accessible to every child who needs them. We're ready to put this support to work building the future of pediatric mental healthcare.